Global Cerebrovascular Disease Market Size, Status and Forecast 2019-2025
Table of Content
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Cerebrovascular Disease Revenue
- 1.4 Market by Type
- 1.4.1 Global Cerebrovascular Disease Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Carotid Endarterectomy
- 1.4.3 Carotid Angioplasty Or Carotid Artery Stenting
- 1.4.4 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
- 1.5 Market by Application
- 1.5.1 Global Cerebrovascular Disease Market Share by Application: 2020 VS 2026
- 1.5.2 Academic & Research Institutes
- 1.5.3 Pharmaceutical & Biotechnology Companies
- 1.5.4 Hospitals & Diagnostic Centers
- 1.5.5 Contract Research Organizations
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Global Cerebrovascular Disease Market Perspective (2015-2026)
- 2.2 Global Cerebrovascular Disease Growth Trends by Regions
- 2.2.1 Cerebrovascular Disease Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Cerebrovascular Disease Historic Market Share by Regions (2015-2020)
- 2.2.3 Cerebrovascular Disease Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Cerebrovascular Disease Market Growth Strategy
- 2.3.6 Primary Interviews with Key Cerebrovascular Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Cerebrovascular Disease Players by Market Size
- 3.1.1 Global Top Cerebrovascular Disease Players by Revenue (2015-2020)
- 3.1.2 Global Cerebrovascular Disease Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Cerebrovascular Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Cerebrovascular Disease Market Concentration Ratio
- 3.2.1 Global Cerebrovascular Disease Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Cerebrovascular Disease Revenue in 2019
- 3.3 Cerebrovascular Disease Key Players Head office and Area Served
- 3.4 Key Players Cerebrovascular Disease Product Solution and Service
- 3.5 Date of Enter into Cerebrovascular Disease Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Cerebrovascular Disease Historic Market Size by Type (2015-2020)
- 4.2 Global Cerebrovascular Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
- 5.1 Global Cerebrovascular Disease Market Size by Application (2015-2020)
- 5.2 Global Cerebrovascular Disease Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Cerebrovascular Disease Market Size (2015-2020)
- 6.2 Cerebrovascular Disease Key Players in North America (2019-2020)
- 6.3 North America Cerebrovascular Disease Market Size by Type (2015-2020)
- 6.4 North America Cerebrovascular Disease Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Cerebrovascular Disease Market Size (2015-2020)
- 7.2 Cerebrovascular Disease Key Players in Europe (2019-2020)
- 7.3 Europe Cerebrovascular Disease Market Size by Type (2015-2020)
- 7.4 Europe Cerebrovascular Disease Market Size by Application (2015-2020)
8 China
- 8.1 China Cerebrovascular Disease Market Size (2015-2020)
- 8.2 Cerebrovascular Disease Key Players in China (2019-2020)
- 8.3 China Cerebrovascular Disease Market Size by Type (2015-2020)
- 8.4 China Cerebrovascular Disease Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Cerebrovascular Disease Market Size (2015-2020)
- 9.2 Cerebrovascular Disease Key Players in Japan (2019-2020)
- 9.3 Japan Cerebrovascular Disease Market Size by Type (2015-2020)
- 9.4 Japan Cerebrovascular Disease Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Cerebrovascular Disease Market Size (2015-2020)
- 10.2 Cerebrovascular Disease Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Cerebrovascular Disease Market Size by Type (2015-2020)
- 10.4 Southeast Asia Cerebrovascular Disease Market Size by Application (2015-2020)
11 India
- 11.1 India Cerebrovascular Disease Market Size (2015-2020)
- 11.2 Cerebrovascular Disease Key Players in India (2019-2020)
- 11.3 India Cerebrovascular Disease Market Size by Type (2015-2020)
- 11.4 India Cerebrovascular Disease Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Cerebrovascular Disease Market Size (2015-2020)
- 12.2 Cerebrovascular Disease Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Cerebrovascular Disease Market Size by Type (2015-2020)
- 12.4 Central & South America Cerebrovascular Disease Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Johnson & Johnson
- 13.1.1 Johnson & Johnson Company Details
- 13.1.2 Johnson & Johnson Business Overview
- 13.1.3 Johnson & Johnson Cerebrovascular Disease Introduction
- 13.1.4 Johnson & Johnson Revenue in Cerebrovascular Disease Business (2015-2020))
- 13.1.5 Johnson & Johnson Recent Development
- 13.2 Amgen
- 13.2.1 Amgen Company Details
- 13.2.2 Amgen Business Overview
- 13.2.3 Amgen Cerebrovascular Disease Introduction
- 13.2.4 Amgen Revenue in Cerebrovascular Disease Business (2015-2020)
- 13.2.5 Amgen Recent Development
- 13.3 GlaxoSmithKline
- 13.3.1 GlaxoSmithKline Company Details
- 13.3.2 GlaxoSmithKline Business Overview
- 13.3.3 GlaxoSmithKline Cerebrovascular Disease Introduction
- 13.3.4 GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2015-2020)
- 13.3.5 GlaxoSmithKline Recent Development
- 13.4 Sanofi-Aventis
- 13.4.1 Sanofi-Aventis Company Details
- 13.4.2 Sanofi-Aventis Business Overview
- 13.4.3 Sanofi-Aventis Cerebrovascular Disease Introduction
- 13.4.4 Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2015-2020)
- 13.4.5 Sanofi-Aventis Recent Development
- 13.5 Merck
- 13.5.1 Merck Company Details
- 13.5.2 Merck Business Overview
- 13.5.3 Merck Cerebrovascular Disease Introduction
- 13.5.4 Merck Revenue in Cerebrovascular Disease Business (2015-2020)
- 13.5.5 Merck Recent Development
- 13.6 Sangamo BioSciences
- 13.6.1 Sangamo BioSciences Company Details
- 13.6.2 Sangamo BioSciences Business Overview
- 13.6.3 Sangamo BioSciences Cerebrovascular Disease Introduction
- 13.6.4 Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2015-2020)
- 13.6.5 Sangamo BioSciences Recent Development
- 13.7 Aldagen
- 13.7.1 Aldagen Company Details
- 13.7.2 Aldagen Business Overview
- 13.7.3 Aldagen Cerebrovascular Disease Introduction
- 13.7.4 Aldagen Revenue in Cerebrovascular Disease Business (2015-2020)
- 13.7.5 Aldagen Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Description
Cerebrovascular Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cerebrovascular Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Johnson & Johnson
Amgen
GlaxoSmithKline
Sanofi-Aventis
Merck
Sangamo BioSciences
Aldagen
...
Market segment by Type, the product can be split into
Carotid Endarterectomy
Carotid Angioplasty Or Carotid Artery Stenting
Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
Market segment by Application, split into
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Contract Research Organizations
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America